Microencapsulation of Banana Passion Fruit (<i>Passiflora tripartita Var. Mollissima</i>): A New Alternative as a Natural Additive as Antioxidant

Banana passion fruit (P. tripartita var. Mollissima) is one of the most promising tropical fruits giving its antioxidant activity (AOA) to replace synthetic additives. Despite this property, there are no studies about the metabolites responsible for its biological function or proposals for the application of technologies, such as microencapsulation by spray drying, to improve its properties and ease its incorporation in several food matrices. The aim of this study is to microencapsulate the pulp of banana passion fruit with several mixtures of encapsulants and identify which one of these mixtures is better to preserve its AOA. The antioxidant activity values for the banana passion fruit pulp were as follows: DPPH: 6630.2 ± 91 μMtrolox/100g;ABTS: 18764.3 ± 270.4 μMtrolox/100g;FRAP: 1703.6± 938.2 mgAA/100g, ORAC: 8105.4 ± 424.2 μmol TEAC/100g of sample;Total phenols: 8862.2 ± 451.4 gallic ac. mg/100g. The concentrations of the bioactive compounds expressed in mg of gallic acid per 100 g of the pulp on a dry base were 13.9 ± 0.004;5.9 ± 0.001 and 126.3 ± 0.004 for caffeic, p-coumaric and ferulic acids, respectively. The best shelf-life followed by ABTS in eight assays was between 28.8 and 31.5 weeks using maltodextrin and modified starch, MD:MS (1/4:3/4) and MD:MS (0:1), respectively. In conclusion, ABTS is the best method to measure the AOA in banana passion fruit because it correlated with the phenolic compounds better than DPPH and FRAP methods. Additionally, two options were found to protect the AOA and to extent the shelf-life of the passion fruit by spray-drying, with mixtures of encapsulants widely used in the food industry.

Impact of formulation parameters on physical characteristics of spray dried nanoemulsions and their reconstitutions

Nanoemulsion as small droplet dispersion allows them to uniformly deposit on substrates,increases the rate of bioavailability,absorption and has a better uptake.Although it is generally accepted that nanoemulsions are stable for years,Oswald ripening which can damage nanoemulsion has been reported[1].In this study,converting nanoemulsion as liquid formulation into solid powders was attempted by using spray drying method.The obtained powders were then characterized,reconstituted and compared to the initial nanoemulsion.

Ibuprofen-Maltodextrin Interaction: Study of Enantiomeric Recognition and Complex Characterization

The interaction between ibuprofen and maltodextrins with different dextrose equivalent was studied in solution and solid state in order to investigate the effect on the solubility of ibuprofen and to determine their usefulness in terms of chiral recognition. Apparent binding constants were calculated using nuclear magnetic resonance spectroscopy experiments and solubility studies. The results showed an increase in the apparent solubility of ibuprofen in the presence of maltodextrins that depended on their ionization state. The freeze-drying method was used to prepare solid complexes, while physical mixtures were obtained by simple blending. These solid systems were characterized in the solid state using differential scanning calorimetry, thermogravimetric analysis, Fourier Transform-Infrared spectroscopy, scanning electron microscopy and X-ray diffractometry. Detailed nuclear magnetic resonance studies provided evidence of the influence of the type and concentration of the maltodextrin host on the chiral recognition of racemic ibuprofen, indicating that these linear ligands act as chiral selectors.

Paclitaxel formulation with stable sustained-release behavior and its biological safety evaluation

Biological safety and stable sustained-release of the drug are two crucial issues involved in the formulation of paclitaxel.Focusing on these issues, by using the FDA approved polylactide as carrier material, soybean lecithin as surfactant and maltodextrin as thickener, paclitaxel loaded PLA microspheres were simply prepared by solvent evaporation, thus guaranteeing the biological safety. The introduction of maltodextrin as a thickener aided to a stable sustained-release of paclitaxel. Surface morphology, particle size, drug loading rate, encapsulation efficiency and in vitro drug release behavior were investigated.Biological safety evaluations such as acute toxicity, allergies, hemolysis, skin stimulation and genotoxicity test were also carried out. Results showed that the obtained microspheres were biocompatible and could release paclitaxel at a desirable constant rate.Therefore, the simply prepared paclitaxel formulation with good biological safety and desirable release behavior exhibited great potential of local injection of paclitaxel for the clinical use in the future.

Development and in vitro/in vivo evaluation of controlled release provesicles of a nateglinide–maltodextrin complex

The aim of this study was to characterize the provesicle formulation of nateglinide(NTG)to facilitate the development of a novel controlled release system of NTG with improved efficacy and oral bioavailability compared to the currently marketed NTG formulation(Glinate^(™)60).NTG provesicles were prepared by a slurry method using the non-ionic surfactant,Span 60(SP),and cholesterol(CH)as vesicle forming agents and maltodextrin as a coated carrier.Multilamellar niosomes with narrow size distribution were shown to be successfully prepared by means of dynamic laser scattering(DLS)and field emission scanning electron microscopy(FESEM).The absence of drug-excipient interactions was confirmed by Fourier transform infrared spectroscopy(FT-IR),differential scanning calorimetry(DSC)and X-ray diffraction(XRD)studies.In vitro release of NTG in different dissolution media was improved compared to pure drug.A goat intestinal permeation study revealed that the provesicular formulation(F4)with an SP:CH ratio of 5:5 gave higher cumulative amount of drug permeated at 48 h compared to Glinate^(™)60 and control.A pharmacodynamic study in streptozotocin-induced diabetic rats confirmed that formulation F4 significantly(P<0.05)reduced blood glucose levels in comparison to Glinate 60.Overall the results show that controlled release NTG provesicles offer a useful and promising oral delivery system for the treatment of type Ⅱ diabetes.

Storage stability of freeze-dried colostral whey powders with different additives

Effects of different additives(sucrose and maltodextrin)on storage stability of colostral whey(CW)powders packaged in aluminium-laminated polyethylene pouches were investigated under different storage conditions(4℃and 40%-70%relative humidity(RH),25℃and 50%RH,and 50℃and 20%-60%RH).All the samples stored under 50℃and 20%-60%RH showed the highest levels of lipid oxidation,Maillard reaction,proteolysis,and color difference,and the lowest immunoglobulin G(IgG)retention.Moisture contents showed an increase trend with increasing RH.Addition of sucrose into CW powders increased water adsorption capacity and Maillard reaction,whereas addition of maltodextrin showed the opposite effects.Maltodextrin as drying aids was suitable for keeping quality during storage.Sucrose did not clearly play any roles in protecting denaturation of IgG during 90-day storage.The low storage temperature and RH were helpful for keeping storage stability of CW powders with different additives.

In vitro assessment of the effect of microencapsulation techniques on the stability,bioaccessibility and bioavailability of mulberry leaf bioactive compounds

Mulberry(Morus alba L.)leaf extract is well-known for its health-promoting features.However,food processing conditions affect its bioactive profile,which could be limited by encapsulation.Nevertheless,assessing the impact of encapsulating techniques on the digestibility of embedded biocompounds requires further knowledge.Hence,the aimed of this study was to assess the effects of carrier materials and drying techniques on(i)bioaccessibility and bioavailability indexes,(ii)stability of nutraceuticals,and(iii)changes in antioxidant activities of mulberry leaf extract powder by using an in vitro oral-gastrointestinal digestion.Digestion was performed out at 37°C in darkness by shaking encapsulated extract with human saliva during 2 min,followed by 2 h of incubation with a pepsin-HCl mixture,then mixed for 2 h with bile salts and pancreatin.After digestion the samples were acidified and HPLC assayed.A significant(p<0.05)decrease in nutraceuticals content was noted during the intestinal phase with more reduction in gamma-aminobutyric acid(34.91–51.14%)compared to that of flavonols(16.58–28.90%),1-deoxynojirimycin(17.56–20.42%)and phenolic acids(0.53–0.67%)in the gastric digesta.Although encapsulation was observed to enhance the bioaccessibility,negative effects were found in terms of the bioefficiency and bioavailability.Furthermore,encapsulation techniques mostly affected the ion reducing capacity than the radical scavenging capacity.The outcomes suggested that carriers had a major effect on the digestibility and antioxidative activity,whilst the drying techniques mostly affect the bioaccessibility and bioavailability of the flavonols.